Autopsy report · NCT03472118

High Flow Oxygen in Patients Undergoing Suspension Laryngoscopy Under General Anesthesia

“Risk-benefit analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 7 months before it stopped.
• 29 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

CMC Ambroise Paré

Sponsor type

University, hospital or other

Conditions

Laryngoscopy; Apnea; Anesthesia

Interventions

Nasal High Flow Oxygen

Participants

29

Sites

2

Countries

France

Trials that died the same way

• A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
  “Adverse change in the risk/benefit” (73% match in meaning)
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care
  “The benefit-risk profile no longer supports continuing the study” (63% match in meaning)
• MB-CART20.1 Melanoma
  “The risk-benefit assessment was not as expected.” (60% match in meaning)
• A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)
  “Study terminated due to an unfavorable risk-benefit analysis” (59% match in meaning)
• Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
  “Trial terminated based on benefit-risk profile assessment” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.